World PulseNow
Newsletter

Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149

The Wall Street Journal•Tuesday, November 4, 2025 at 11:27:00 PM
PositiveFinancial Markets
Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149
Former President Trump is in talks with Novo Nordisk, the maker of Ozempic, to negotiate a deal that could allow some weight-loss drugs to be sold for just $149. This move could also lead to Medicare and Medicaid coverage for these popular medications, benefiting many individuals seeking effective weight-loss solutions.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended Readings
Trump re-nominates Musk ally Jared Isaacman for position of NASA chief
Investing.coman hour ago
Trump re-nominates Musk ally Jared Isaacman for position of NASA chief
PositiveFinancial Markets
In a significant move, President Trump has re-nominated Jared Isaacman, a close ally of Elon Musk, for the position of NASA chief. This decision highlights the administration's commitment to advancing space exploration and innovation.
Read full article
via Investing.com
Trump signs order formally cutting fentanyl tariffs against China to 10%
Investing.coman hour ago
Trump signs order formally cutting fentanyl tariffs against China to 10%
PositiveFinancial Markets
In a significant move, Trump has signed an order to reduce tariffs on fentanyl imports from China to 10%. This decision aims to address the ongoing opioid crisis by making it easier to access necessary resources while fostering better trade relations.
Read full article
via Investing.com
Lawmakers are hopeful they can reach a bipartisan deal to end the government shutdown. Trump again demanded Republicans bypass Democrats and reopen government
The Wall Street Journalan hour ago
Lawmakers are hopeful they can reach a bipartisan deal to end the government shutdown. Trump again demanded Republicans bypass Democrats and reopen government
NeutralFinancial Markets
Lawmakers are expressing optimism about reaching a bipartisan agreement to end the government shutdown. Meanwhile, President Trump has reiterated his call for Republicans to bypass Democrats and reopen the government by ending the Senate filibuster.
Read full article
via The Wall Street Journal
Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, source says
Investing.com2 hours ago
Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, source says
PositiveFinancial Markets
Lilly and Novo are reportedly close to agreements that could lower the prices of obesity drugs and improve access to Medicare. This development is seen as a positive step towards making essential medications more affordable for those in need.
Read full article
via Investing.com
Elections in US to give voters’ verdict on Trump
Financial Times3 hours ago
Elections in US to give voters’ verdict on Trump
NeutralFinancial Markets
The upcoming elections across states like New York and Virginia are set to reflect the electorate's mood regarding President Trump's second term. Voters will have the opportunity to express their opinions and influence the political landscape.
Read full article
via Financial Times
Trump’s breaking-the-china strategy isn’t working: Despite the global collateral damage, only modest progress has been made with China
Fortune5 hours ago
Trump’s breaking-the-china strategy isn’t working: Despite the global collateral damage, only modest progress has been made with China
NegativeFinancial Markets
Trump's recent visit to China has highlighted the shortcomings of his tariff strategies, showing that despite significant global repercussions, only limited progress has been achieved. This situation poses serious challenges for American businesses and consumers alike.
Read full article
via Fortune
Trump administration can reconsider SouthCoast Wind approval, judge rules
Investing.com5 hours ago
Trump administration can reconsider SouthCoast Wind approval, judge rules
NeutralFinancial Markets
A judge has ruled that the Trump administration can revisit its approval of the SouthCoast Wind project. This decision opens the door for potential changes to the project's status, reflecting ongoing discussions about renewable energy initiatives.
Read full article
via Investing.com
Shutdown Strain Could Impact VA Governor's Race
Bloomberg5 hours ago
Shutdown Strain Could Impact VA Governor's Race
NegativeFinancial Markets
Former Virginia Governor Terry McAuliffe believes that the ongoing government shutdown will lead voters, particularly federal workers, to express their frustrations at the polls today, potentially impacting the election results against Trump and the Republicans.
Read full article
via Bloomberg
Latest from Financial Markets
Private-Credit Earnings Ease Investor Concern Over Asset Class’s Health
The Wall Street Journal27 minutes ago
Private-Credit Earnings Ease Investor Concern Over Asset Class’s Health
PositiveFinancial Markets
Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the stability of the sector.
Read full article
via The Wall Street Journal
Private-Credit Earnings Ease Investor Concern Over Asset Class’s Health
The Wall Street Journal27 minutes ago
Private-Credit Earnings Ease Investor Concern Over Asset Class’s Health
PositiveFinancial Markets
Apollo CEO Marc Rowan has reassured investors by addressing concerns regarding the health of the private-credit asset class, easing worries and highlighting the sector's resilience.
Read full article
via The Wall Street Journal
Aviat Networks Q1 FY2026 slides: Revenue jumps 21.4%, exceeding expectations
Investing.com30 minutes ago
Aviat Networks Q1 FY2026 slides: Revenue jumps 21.4%, exceeding expectations
PositiveFinancial Markets
Aviat Networks reported a remarkable 21.4% increase in revenue for Q1 FY2026, surpassing market expectations. This growth highlights the company's strong performance and positive outlook in the telecommunications sector.
Read full article
via Investing.com
Stoke Therapeutics Q3 2025 presentation: strong revenue growth amid clinical progress
Investing.com31 minutes ago
Stoke Therapeutics Q3 2025 presentation: strong revenue growth amid clinical progress
PositiveFinancial Markets
Stoke Therapeutics recently presented its Q3 2025 results, showcasing impressive revenue growth alongside significant advancements in its clinical programs. The company's progress highlights its commitment to developing innovative therapies, making it a key player in the biotechnology sector.
Read full article
via Investing.com
Amgen Q3 2025 slides: Revenue up 12%, guidance raised on strong product performance
Investing.com31 minutes ago
Amgen Q3 2025 slides: Revenue up 12%, guidance raised on strong product performance
PositiveFinancial Markets
Amgen has reported a 12% increase in revenue for Q3 2025, prompting the company to raise its guidance due to strong product performance. This positive trend highlights the effectiveness of their strategies and the growing demand for their offerings.
Read full article
via Investing.com
Corsair Q3 2025 slides show strong growth amid missed earnings forecasts
Investing.com35 minutes ago
Corsair Q3 2025 slides show strong growth amid missed earnings forecasts
NeutralFinancial Markets
Corsair's Q3 2025 slides indicate a strong growth trajectory, despite missing earnings forecasts. The company is navigating challenges while showcasing resilience in its performance.
Read full article
via Investing.com